Historical record - last NADAC effective date: 8/22/2018
Product Information
GLYBURIDE 1.25 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0939 per EA under NDC 68382065601. Its NADAC has been published 99 times since Oct 19, 2016.
FDA first approved this application on May 10, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382065601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/22/2018
Active Ingredients
GLYBURIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206749FDA Approved
5/10/2016
TE Code
AB1
On Market Since
6/2/2016
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 1.25 MG TABLET has been published 99 times since Oct 19, 2016, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0939 per EA |
|---|---|
| All-time high | $0.1371 (Apr 11, 2018) |
| All-time low | $0.0816 (Apr 19, 2017) |
| Median price | $0.1056 |
| Average price | $0.1040 |
| Largest weekly change | +50.1% (Mar 21, 2018) |
| Weeks tracked | 99 |
| Tracking since | Oct 19, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-27.5%
Last surveyed Sep 5, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYBURIDE 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 1.25 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0939 per EA (NDC 68382065601), effective Sep 5, 2018.
How has the price of GLYBURIDE 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 1.25 MG TABLET has declined 27.5%. It has been tracked across 99 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 1.25 MG TABLET?
Since Oct 19, 2016, the NADAC for GLYBURIDE 1.25 MG TABLET has ranged from a low of $0.0816 (Apr 19, 2017) to a high of $0.1371 (Apr 11, 2018), with a median of $0.1056 per EA.
Are there cheaper alternatives to GLYBURIDE 1.25 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURIDE 1.25 MG TABLET, is $0.0674 per EA — about 28% below GLYBURIDE 1.25 MG TABLET.
Who manufactures GLYBURIDE 1.25 MG TABLET?
GLYBURIDE 1.25 MG TABLET (NDC 68382065601) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.